Table 4 The first ATC classification of drugs used by patients with cardiovascular disease
Drug class | Total n = 961 (100%) | Men (Total n = 404) n (%; 95% CI) | Women (Total n = 557) n (%; 95% CI) | 60 years and older (Total n = 441) n (%; 95% CI) |
|---|---|---|---|---|
C: Cardiovascular system | 731 (76.1) | 295 (73.0; 64.9–81.9) | 436 (78.3; 71.1–86.0) | 366 (83.0; 74.7–92.0) |
B: Blood and blood-forming organs | 484 (50.4) | 204 (50.5; 43.8–57.9) | 280 (50.3; 44.5–56.5) | 243 (55.1; 48.4–62.5) |
A: Alimentary tract and metabolism | 326 (33.9) | 107 (26.5; 21.7–32.0) | 219 (39.3; 34.3–44.9) | 169 (38.3; 32.8–44.6) |
G: Genitourinary system | 278 (28.9) | 12 (3.0; 1.5–5.2) | 266 (47.8; 42.2–53.9) | 98 (22.2; 18.0–27.1) |
N: Nervous system | 223 (23.2) | 74 (18.3; 14.4–23.0) | 149 (26.8; 22.6–31.4) | 105 (23.8; 14.5–28.8) |
H: Systemic hormonal preparations* | 166 (17.3) | 52 (12.9; 9.6–16.9) | 114 (20.5; 16.9–24.6) | 82 (18.6; 14.8–23.1) |
M: Musculoskeletal system | 119 (12.4) | 27 (6.7; 4.4–9.7) | 92 (16.5; 13.3–20.3) | 71 (16.1; 12.6–20.3) |
R: Respiratory system | 67 (7.0) | 23 (5.7; 3.6–8.5) | 44 (7.9; 5.7–10.6) | 42 (9.5; 6.9–12.9) |
J: Anti-infectives for systemic use | 16 (1.7) | 7 (1.7; 0.7–3.6) | 9 (1.6; 0.7–3.1) | 4 (0.9; 0.3–2.3) |
S: Sensory organs | 10 (1.0) | 1 (0.3; 0.0–1.4) | 9 (1.6; 0.7–3.1) | 7 (1.6; 0.6–3.3) |